The global cough syrup market size reached US$ 5.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7 Billion by 2027, exhibiting a growth rate (CAGR) of 4.4% during 2022-2027.
Market Outlook:
Cough syrup refers to a combination drug that is used to provide temporary relief from cough, common cold, hay fever, and other respiratory allergies. It is manufactured using non-opioid cough suppressants, expectorants, and antihistamine compounds to block the symptoms. The suppressants help in alleviating the symptoms of dry cough by minimizing the activity of the cough reflex and reducing the urge to cough. The expectorants aid in treating cough with mucus by loosening it, thereby making it easier to expel from the body. The antihistamines are utilized to relieve cough caused by minor throat or airway irritation. Cough syrups are generally prescribed by doctors or are available over-the-counter (OTC) in pharmacy stores in a wide variety of flavors, including cherry, orange, honey, and bubblegum.
Market Trends and Drivers:
The elevating prevalence of upper respiratory tract infection (URTI) and other respiratory disorders across countries is among the key factors stimulating the cough syrup market. Furthermore, the inflating health consciousness among the masses and convenient product availability in pharmacies and general stores are also propelling the global market. Moreover, various innovations, including the development of cough syrups with minimal side effects, are acting as other significant growth-inducing factors. Besides this, manufacturers are developing variants fortified with natural herbs and ingredients with immunity-boosting effects, which is further fueling the market growth. Apart from this, the growing expenditure capacities of the consumers and the expanding pharmaceutical industry are expected to positively influence the cough syrup market in the coming years.
Major Players Covered:
- Acella Pharmaceuticals LLC
- Bayer AG
- GlaxoSmithKline PLC
- Johnson & Johnson
- Pfizer Inc.
- Prestige Consumer Healthcare Inc.
- Reckitt Benckiser Group PLC
- Sanofi
- Sun Pharmaceutical Industries Limited
- The Procter & Gamble Company
Note: We are updating our reports, If you want the latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you via email within 24 to 48 hours.
Get a Free Sample Copy of this Report: https://www.imarcgroup.com/cough-syrup-market/requestsample
Cough Syrup Market Segmentation:
The report has segmented the global cough syrup market on the basis of product type, age group, distribution channel and region.
Based on Product Type:
- Expectorants
- Cough Suppressants/Antitussives
- Combination Medications
Based on Age Group:
- Pediatric
- Adult
Based on Distribution Channel:
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
Geographical Analysis:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Make inquiry before purchase of this report: https://www.imarcgroup.com/request?type=report&id=3917&flag=F
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.